http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RO-108868-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_600db5b93a54999d3db277d10725d525 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 |
| filingDate | 1992-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96da8259bdd9203a1df1fd29fc8a93ac |
| publicationDate | 1994-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RO-108868-B1 |
| titleOfInvention | Indolonafthyridine derivatives and process for their preparation |
| abstract | The invention relates to novelnindolonaphthyridines of the general formula I:nwherein R 1 is hydrogen,nalkyl, alkylcarbonylalkyl,narylcarbonylcarbonyl, aralkylnor carbamoylalkyl, R2 isnthe meaning of R, and morenmay be trifluoromethyl, alkoxynor alkylthio, R3, R4 and R5nx Ynare each independently hydrogen, halogen,nalkyl, alkoxy, alkylthio or trifluoromethyl and X and Ynare each hydrogen or, together, form ana simple link, and a processntheir preparation, antagonist compounds ofnzinc-chloropiperazine-induced hypolocomotion,nwhich are used in the prophylactic treatment ofnmigraines or nervous disorders. |
| priorityDate | 1992-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 51.